Analyst firms · BofA Securities · SAGE

BofA Securities SAGE price target and rating history

Sage Therapeutics Inc. (SAGE) · Health Care

BofA Securities rates Sage Therapeutics Inc. (SAGE) Underperform with a $5 price target, as of its latest action on Mar 11, 2025. It has published 3 rating actions on SAGE since August 2023, including 0 upgrades and 2 downgrades.

Current rating
Underperform
Price target
$5
Median target, all firms
Too few
Actions on SAGE
3

BofA Securities price target on SAGE

$25$15$5202420252026
BofA Securities price target on SAGE, each point a stated target, August 2023 to March 2025.

Every BofA Securities rating on SAGE

Questions about BofA Securities and SAGE

What is BofA Securities's price target for SAGE?
BofA Securities's latest stated price target for Sage Therapeutics Inc. (SAGE) is $5, from its action on Mar 11, 2025.
What is BofA Securities's rating on SAGE?
BofA Securities rates SAGE Underperform, a bearish rating, as of Mar 11, 2025.
When did BofA Securities last change its view on SAGE?
On Mar 11, 2025, BofA Securities resumes coverage at Underperform, price target $5.

More SAGE rating histories

All BofA Securities ratingsSAGE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.